Published in
Taylor and Francis Group, Expert Review of Vaccines, 7(21), p. 975-982, 2022
DOI: 10.1080/14760584.2022.2064280
Links
Tools
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021
Journal article published in 2022 by
Massimo Fabiani 
,
Maria Puopolo,
Antonietta Filia,
Chiara Sacco,
Alberto Mateo-Urdiales,
Stefania Spila Alegiani ,
Martina Del Manso,
Fortunato D’Ancona,
Fenicia Vescio ,
Marco Bressi,
Daniele Petrone,
Matteo Spuri,
Maria Cristina Rota,
Marco Massari,
Roberto Da Cas
and other authors.
,
Maria Puopolo,
Antonietta Filia,
Chiara Sacco,
Alberto Mateo-Urdiales,
Stefania Spila Alegiani ,
Martina Del Manso,
Fortunato D’Ancona,
Fenicia Vescio ,
Marco Bressi,
Daniele Petrone,
Matteo Spuri,
Maria Cristina Rota,
Marco Massari,
Roberto Da Cas
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 